Does erythropoietin have a dark side? Epo signaling and cancer cells
- PMID: 17636183
- DOI: 10.1126/stke.3952007pe38
Does erythropoietin have a dark side? Epo signaling and cancer cells
Abstract
Erythropoietin (Epo) stimulates red blood cell production by docking with its cognate receptor on the erythroid progenitor cell and triggering an array of signaling pathways that inhibit apoptosis and promote cell proliferation and differentiation. In its pharmaceutical forms, epoetin and darbepoetin, Epo is widely used to treat various anemias, including those associated with cancer. The Epo receptor is also expressed by nonhematopoietic cells, including cancer cells, and Epo exhibits a "tissue-protective" effect on nonhematopoietic tissues, possibly mediated through a novel heteroreceptor, blocking apoptosis induced by a variety of insults. The unexpected results of several clinical studies in which Epo was used to treat cancer patients have now raised the question of a potential direct growth-promoting action of Epo on cancer cells.
Similar articles
-
Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line.Mol Cancer Res. 2010 Apr;8(4):615-26. doi: 10.1158/1541-7786.MCR-09-0264. Epub 2010 Mar 30. Mol Cancer Res. 2010. PMID: 20353997
-
The therapeutic potential of erythropoiesis-stimulating agents for tissue protection: a tale of two receptors.Blood Purif. 2010;29(2):86-92. doi: 10.1159/000245630. Epub 2010 Jan 8. Blood Purif. 2010. PMID: 20093809 Review.
-
Physician Education: The Erythropoietin Receptor and Signal Transduction.Oncologist. 1996;1(5):337-339. Oncologist. 1996. PMID: 10388012
-
Turning cells red: signal transduction mediated by erythropoietin.Trends Cell Biol. 2005 Mar;15(3):146-55. doi: 10.1016/j.tcb.2005.01.007. Trends Cell Biol. 2005. PMID: 15752978 Review.
-
Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation.Stem Cells. 2000;18(5):366-73. doi: 10.1634/stemcells.18-5-366. Stem Cells. 2000. PMID: 11007921
Cited by
-
Anaemia: a rare but neglected problem among Finnish patients receiving chemotherapy for solid tumours.Support Care Cancer. 2011 Jan;19(1):149-53. doi: 10.1007/s00520-009-0809-x. Epub 2010 Jan 26. Support Care Cancer. 2011. PMID: 20101415
-
Erythropoietin receptor response circuits.Curr Opin Hematol. 2010 May;17(3):169-76. doi: 10.1097/MOH.0b013e328338008b. Curr Opin Hematol. 2010. PMID: 20173635 Free PMC article. Review.
-
Approaches to the treatment of anaemia in patients with chronic heart failure.Heart Fail Rev. 2008 Dec;13(4):431-8. doi: 10.1007/s10741-008-9085-y. Epub 2008 Apr 8. Heart Fail Rev. 2008. PMID: 18392791 Review.
-
The role of iron in tumour cell proliferation.Clin Transl Oncol. 2011 Feb;13(2):71-6. doi: 10.1007/s12094-011-0621-1. Clin Transl Oncol. 2011. PMID: 21324793 Review.
-
Chronic Administration of Recombinant Human Erythropoietin Induces Angiogenesis in Healthy Mouse Brain.Cureus. 2024 Sep 1;16(9):e68362. doi: 10.7759/cureus.68362. eCollection 2024 Sep. Cureus. 2024. PMID: 39355466 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous